Publications

Safety of sulfadoxine/pyrimethamine for intermittent preventive treatment of malaria in infants: evidence from large-scale operational research in southern Tanzania.

Maokola, W; Chemba, M; Hamisi, Y; Mrisho, M; Shirima, K; Manzi, F; Masanja, M; WILLEY, B; Alonso, P; Mshinda, H; Tanner, M; SCHELLENBERG, JR M A; SCHELLENBERG, D;

2011

International health, (2011).3 3 10.1016/j.inhe.2011.03.009.

Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.

Villegas-Mendez, A; De Souza, JB; Murungi, L; HAFALLA, JC R; Shaw, TN; Greig, R; RILEY, EM; Couper, KN;

2011

Journal of immunology (Baltimore, Md, (2011).187 6 10.4049/jimmunol.1100241.

Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: provider knowledge and acceptability.

Smith Paintain, L; Antwi, GD; JONES, C; Amoako, E; Adjei, RO; Afrah, NA; GREENWOOD, B; CHANDRAMOHAN, D; TAGBOR, H; WEBSTER, J;

2011

PloS one, (2011).6 8 10.1371/journal.pone.0024035.

Socially-marketed rapid diagnostic tests and ACT in the private sector: ten years of experience in Cambodia.

YEUNG, S; PATOUILLARD, E; Allen, H; Socheat, D;

2011

Malaria journal, (2011).10 1 10.1186/1475-2875-10-243.

Vital functions of the malarial ookinete protein, CTRP, reside in the A domains.

Ramakrishnan, C; DESSENS, JT; Armson, R; Pinto, SB; Talman, AM; Blagborough, AM; Sinden, RE;

2011

International journal for parasitology, (2011).41 10 10.1016/j.ijpara.2011.05.007.

The importance of considering community-level effects when selecting insecticidal malaria vector products.

Killeen, GF; Okumu, FO; N'GUESSAN, R; Coosemans, M; Adeogun, A; Awolola, S; Etang, J; Dabiré, RK; Corbel, V;

2011

Parasites & vectors, (2011).4 1 10.1186/1756-3305-4-160.

Malaria morbidity in children in the year after they had received intermittent preventive treatment of malaria in Mali: a randomized control trial.

Dicko, A; Barry, A; Dicko, M; Diallo, AI; Tembine, I; Dicko, Y; Dara, N; Sidibe, Y; Santara, G; Conaré, T; CHANDRAMOHAN, D; COUSENS, S; MILLIGAN, PJ; Diallo, DA; Doumbo, OK; GREENWOOD, B;

2011

PloS one, (2011).6 8 10.1371/journal.pone.0023390.

Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial.

Konaté, AT; Yaro, JB; Ouédraogo, AZ; Diarra, A; Gansané, A; Soulama, I; Kangoyé, DT; Kaboré, Y; Ouédraogo, E; Ouédraogo, A; Tiono, AB; Ouédraogo, IN; CHANDRAMOHAN, D; COUSENS, S; MILLIGAN, PJ; Sirima, SB; GREENWOOD, BM; Diallo, DA;

2011

PloS one, (2011).6 8 10.1371/journal.pone.0023391.

Drug-resistant genotypes and multi-clonality in Plasmodium falciparum analysed by direct genome sequencing from peripheral blood of malaria patients.

Robinson, T; CAMPINO, SG; Auburn, S; Assefa, SA; Polley, SD; Manske, M; MacInnis, B; Rockett, KA; Maslen, GL; Sanders, M; Quail, MA; CHIODINI, PL; Kwiatkowski, DP; CLARK, TG; SUTHERLAND, CJ;

2011

PloS one, (2011).6 8 10.1371/journal.pone.0023204.

Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.

Naidoo, I; ROPER, C;

2011

Parasitology, (2011).138 12 10.1017/S0031182011000746.